Link to Pubmed [PMID] – 1521169
C. R. Acad. Sci. III, Sci. Vie 1992;314(11):499-504
In murine models, we show that the growth of a transplanted tumor can be controlled when allogeneic or xenogeneic cells expressing high levels of interleukin-2 are co-injected with the syngeneic tumor cells. Thus, genetically modified allogeneic or xenogeneic cells could have some therapeutic potential as vectors for transient cytokine gene expression.